ARTICLE | Management Tracks
Merck KGaA’s Rossetti retires; plus moves at J&J, Innovent, eFFECTOR, Nautilus, Epirium and more
October 17, 2020 2:46 AM UTC
Luciano Rossetti will retire at year-end from Merck KGaA (Xetra:MRK) after a six-year tenure as global head of R&D for the healthcare business sector. Rossetti’s successors are Danny Bar-Zohar, who will join the organization on Nov. 1 as global head of development; and Joern-Peter Halle, who will continue to serve as global head of research for the healthcare business sector.
The Janssen Pharmaceuticals of Johnson & Johnson (NYSE:JNJ) promoted Chris Hourigan to company group chairman for the Asia-Pacific region. He was president of the Japan unit, and succeeds Ai Hua Ong. ...